Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-18T18:40:29.436Z Has data issue: false hasContentIssue false

Interventions to improve lifestyle and quality of life in patients with concurrent mental illness and substance use

Published online by Cambridge University Press:  23 March 2020

A. Juel
Affiliation:
Aarhus University Hospital, Department of Affective Disorders, Randers NO, Denmark
C.B. Kristiansen
Affiliation:
Southern University of Denmark, Department of Psychiatry, Odense, Denmark
P. Munk-Jørgensen
Affiliation:
Southern University of Denmark, Department of Psychiatry, Odense, Denmark
P. Hjorth
Affiliation:
Psychiatric Hospital Randers, Mental Health Center, Randers, Denmark

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background

Patients with co-existence of psychiatric disorders and substance use have an increased risk of premature death. This is attributable to a higher prevalence of physical comorbidities and the lifestyle related to substance use. Furthermore, they experience low quality of life (QoL). Studies addressing lifestyle interventions for these patients are warranted.

Aims

To investigate the physical health and QoL in patients with co-existence of psychiatric disorders and substance use, and to analyse for changes in their (a) health, (b) substance use and (c) QoL after a 24-month health-promotion programme. Further aims were to investigate associations between (a) QoL and number of interventions, (b) QoL and patient characteristics and (c) QoL and length of participation in the intervention.

Methods

In this naturalistic cohort study, 64 non-selected patients were engaged in health-promoting interventions added to contemporary treatments. QoL and clinical variables were measured at the beginning of and continuously during the programme by means of the WHOQoL-Bref questionnaire.

Results

At enrolment, the patients’ intake of cannabis and alcohol was high. During follow-up, patients consumed significantly fewer caffeinated beverages (P = 0.038) and fast-food meals (P = 0.018), and slept significantly less (P = 0.032). The average dose of antipsychotic medication increased significantly (P = 0.015). QoL was low at enrolment but improved significantly overall (P = 0.009) and in the psychological (P = 0.020) and environmental domains (P = 0.012) at follow-up. The difference in total QoL was positively associated with the number of interventions attended.

Conclusion

This programme shows promise in addressing health promotion for these patients and can easily be integrated into contemporary treatments.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
e-Poster viewing: Substance related and addictive disorders
Copyright
Copyright © European Psychiatric Association 2017
Submit a response

Comments

No Comments have been published for this article.